Chemicon and Cellumen Announce an R&D Agreement

News   Feb 09, 2006

 
Chemicon and Cellumen Announce an R&D Agreement
 
 
 

RELATED ARTICLES

Avacta Group plc announces successful outcome of “Gene Delivery” collaboration with FIT Biotech

News

Sustained production of Affimer drugs by muscle tissue in vivo could lead to major patient and commercial benefits.

READ MORE

New Chemistry to Make Smart Drugs Smarter

News

A method to activate targeted drugs, or smart drugs, only at the selected site of action, an approach that improves the drug’s therapeutic effect and minimizes side effects, has been developed in a study led by Georgia State University.

READ MORE

XenoGesis and BioAscent Forge Alliance to Offer Enhanced Integrated Drug Discovery Services

News

XenoGesis and BioAscent Discovery Limited have announced a collaboration to offer an enhanced range of integrated drug discovery services, including medicinal chemistry, biology and DMPK.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE